NCT03549195 TMTP1 Targeting Micro-metastasis LN in Laparoscopic SLN Detection in Cervical Cancer Status UNKNOWN Phase NA
NCT03546855 Apatinib Treating Patients With Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy. Status UNKNOWN Phase PHASE2
NCT03542513 First-void Urine Samples for the Follow-up of Women Treated for High-grade Cervical Intraepithelial Neoplasia (CIN) Status COMPLETED Phase N/A
NCT03540069 Reducing Barriers and Sustaining Utilization of a Cervical Cancer Screening Program in Rural Senegal Status COMPLETED Phase NA
NCT03538028 A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies Status COMPLETED Phase PHASE1
NCT03527264 BrUOG 355: Nivolumab to Tailored Radiation Therapy With Concomitant Cisplatin in the Treatment of Patients With Cervical Cancer Status TERMINATED Phase PHASE2
NCT03517488 A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03514459 Testing an Implementation Science Tool to Increase Cervical Cancer Screening in Mombasa, Kenya Status COMPLETED Phase NA
NCT03495882 Subjects With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors (Cervical) Status COMPLETED Phase PHASE1/PHASE2
NCT03483610 Promoting Cervical Cancer Screening for Emergency Department Patients Status COMPLETED Phase NA
NCT03476798 Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium Status COMPLETED Phase PHASE2
NCT03476018 Trial to Optimally Show the Pharmacological Action of Z-100 Status COMPLETED Phase PHASE3
NCT03468010 A Trial Comparing Adjuvant Chemotherapy With Observation After Concurrent Chemoradiotherapy of Cervical Cancer (With Pelvic or Para-aortic Node Involvement) Status UNKNOWN Phase PHASE3
NCT03454451 CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers Status COMPLETED Phase PHASE1
NCT03444376 The Combination of GX-188E Vaccination and Pembrolizumab in Patients With HPV 16 and/or 18+ Advanced Cervical Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT03423082 Pilot Study to Assess the Potential Clinical Utility of 18F Fluciclovine PET for Cervical and Endometrial Cancer. Status TERMINATED Phase PHASE4
NCT03413579 Evaluate Efficacy of the Association Nimotuzumab(HR3) /Cisplatin-Vinorelbine on Patients With Cervical Carcinom Status COMPLETED Phase PHASE3